A structured view of a disease, modality, or target landscape — company, asset, and mechanism mapping with strategic implications.
RevaIQ combines structured evidence, automated monitoring and senior analyst interpretation to support important life-sciences decisions.
A defined scope, source-linked evidence, clear analyst judgment, prioritized implications, and delivery through reports, alerts, and the RevaIQ workspace.
A repeatable, transparent process from business question to action.
Scope and key intelligence questions.
Competitors and evidence.
Approved sources.
Triangulate.
Implications.
Recommended action.